Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). (Q40884697)

24 September 2017

1 reference

title

Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). (English)

1 reference

24 September 2017

0 references

Wu AW

1

1 reference

24 September 2017

Revicki DA

series ordinal

2

1 reference

24 September 2017

Jacobson D

series ordinal

3

1 reference

24 September 2017

Malitz FE

series ordinal

4

1 reference

24 September 2017

1 August 1997

1 reference

24 September 2017

Quality of Life Research

1 reference

24 September 2017

6

1 reference

24 September 2017

481-493

1 reference

24 September 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1018451930750

24 September 2017

0 references

cites work

Functional status and well-being in a placebo-controlled trial of zidovudine in early symptomatic HIV infection.

1 reference

12 December 2020

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases

1 reference

12 December 2020

The MOS short-form general health survey. Reliability and validity in a patient population

1 reference

12 December 2020

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group

1 reference

12 December 2020

Methods for quality-of-life studies

1 reference

12 December 2020

The reliability and validity of two HIV-specific health-related Quality-of-Life measures: a preliminary analysis

1 reference

12 December 2020

Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team

1 reference

12 December 2020

Quality of life assessment in pregnant women with the human immunodeficiency virus

1 reference

12 December 2020

Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collabor

1 reference

12 December 2020

Measuring visual function and quality of life in patients with cytomegalovirus retinitis. Development of a questionnaire. Studies of Ocular Complication of AIDS Research Group

1 reference

12 December 2020

Pain in human immunodeficiency virus disease: a review

1 reference

12 December 2020

Comparison of health-related quality of life in clinical trial and nonclinical trial human immunodeficiency virus-infected cohorts.

1 reference

12 December 2020

The use of two measures of health-related quality of life in HIV-infected individuals: a cross-sectional comparison.

1 reference

12 December 2020

Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108

1 reference

12 December 2020

A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection

1 reference

12 December 2020

Effect sizes for interpreting changes in health status.

1 reference

12 December 2020

Assessing the needs and quality of life of patients with HIV infection: development of the HIV Overview of Problems-Evaluation System (HOPES)

1 reference

12 December 2020

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

12 December 2020

Change in clinical status, health status, and health utility outcomes in HIV-infected patients.

1 reference

12 December 2020

SF-20 score and item distributions in a human immunodeficiency virus-seropositive sample

1 reference

12 December 2020

Psychosocial vulnerability to stress: a study of HIV-positive homosexual men.

1 reference

12 December 2020

The effect of mode of administration on medical outcomes study health ratings and EuroQol scores in AIDS.

1 reference

12 December 2020

Validity of the Quality of Well-Being Scale for persons with human immunodeficiency virus infection. HNRC Group. HIV Neurobehavioral Research Center

1 reference

12 December 2020

Health status assessment. Completing the clinical database

1 reference

12 December 2020

Quality of life outcomes of saquinavir, zalcitabine and combination saquinavir plus zalcitabine therapy for adults with advanced HIV infection with CD4 counts between 50 and 300 cells/mm3.

1 reference

12 December 2020

Validity and responsiveness of the euroqol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial.

1 reference

12 December 2020

Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting. A randomized, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Reliability and validity of French, German, Italian, Dutch, and UK English translations of the Medical Outcomes Study HIV Health Survey.

1 reference

12 December 2020

Evaluating translations of health status questionnaires. Methods from the IQOLA project. International Quality of Life Assessment

1 reference

12 December 2020

Reliability and validity of an HIV-specific health-related quality-of-life measure for use with injecting drug users.

1 reference

12 December 2020

Reliability and validity of physical and mental health summary scores from the Medical Outcomes Study HIV Health Survey.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1018451930750

1 reference

Dimensions Publication ID

24 September 2017

0 references

1 reference